vs
STANDARD BIOTOOLS INC.（LAB）与NorthEast Community Bancorp, Inc.（NECB）财务数据对比。点击上方公司名可切换其他公司
NorthEast Community Bancorp, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.4倍（$26.4M vs $19.6M），NorthEast Community Bancorp, Inc.净利率更高（40.9% vs -177.4%，领先218.3%），NorthEast Community Bancorp, Inc.同比增速更快（3.9% vs -11.5%），NorthEast Community Bancorp, Inc.自由现金流更多（$50.8M vs $-23.1M），过去两年NorthEast Community Bancorp, Inc.的营收复合增速更高（1.8% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
东北社区银行（马里兰州）是一家美国银行控股公司，主要在大西洋中部地区运营，面向个人用户和本地企业提供存款业务、抵押贷款、小微企业融资、财富管理等全品类零售及商业金融服务。
LAB vs NECB — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $26.4M |
| 净利润 | $-34.7M | $10.8M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 59.0% |
| 净利率 | -177.4% | 40.9% |
| 营收同比 | -11.5% | 3.9% |
| 净利润同比 | -28.8% | 5.8% |
| 每股收益（稀释后） | $-0.09 | $0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $26.4M | ||
| Q3 25 | $19.6M | $27.0M | ||
| Q2 25 | $21.8M | $25.9M | ||
| Q1 25 | $40.8M | $25.5M | ||
| Q4 24 | — | $25.4M | ||
| Q3 24 | $22.1M | $27.6M | ||
| Q2 24 | $22.5M | $27.0M | ||
| Q1 24 | $45.5M | $25.5M |
| Q4 25 | — | $10.8M | ||
| Q3 25 | $-34.7M | $11.9M | ||
| Q2 25 | $-33.5M | $11.2M | ||
| Q1 25 | $-26.0M | $10.6M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $-26.9M | $12.7M | ||
| Q2 24 | $-45.7M | $12.8M | ||
| Q1 24 | $-32.2M | $11.4M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 59.0% | ||
| Q3 25 | -168.5% | 61.6% | ||
| Q2 25 | -118.1% | 59.5% | ||
| Q1 25 | -80.8% | 57.4% | ||
| Q4 24 | — | 57.0% | ||
| Q3 24 | -120.9% | 63.6% | ||
| Q2 24 | -134.5% | 65.6% | ||
| Q1 24 | -132.2% | 62.7% |
| Q4 25 | — | 40.9% | ||
| Q3 25 | -177.4% | 44.0% | ||
| Q2 25 | -153.7% | 43.1% | ||
| Q1 25 | -63.8% | 41.4% | ||
| Q4 24 | — | 40.1% | ||
| Q3 24 | -122.0% | 45.9% | ||
| Q2 24 | -203.3% | 47.5% | ||
| Q1 24 | -70.6% | 44.5% |
| Q4 25 | — | $0.78 | ||
| Q3 25 | $-0.09 | $0.87 | ||
| Q2 25 | $-0.09 | $0.82 | ||
| Q1 25 | $-0.07 | $0.78 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | $-0.07 | $0.95 | ||
| Q2 24 | $-0.12 | $0.97 | ||
| Q1 24 | $-0.27 | $0.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $81.2M |
| 总债务越低越好 | — | $70.0M |
| 股东权益账面价值 | $399.7M | $351.7M |
| 总资产 | $539.6M | $2.1B |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
| Q4 25 | — | $81.2M | ||
| Q3 25 | $129.4M | $64.3M | ||
| Q2 25 | $158.6M | $59.4M | ||
| Q1 25 | $150.9M | $89.5M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | $210.6M | $97.8M | ||
| Q2 24 | $269.8M | $113.9M | ||
| Q1 24 | $287.1M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | — | $170.0M | ||
| Q2 25 | — | $135.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | $7.0M | ||
| Q2 24 | $55.1M | $47.0M | ||
| Q1 24 | $55.0M | $47.0M |
| Q4 25 | — | $351.7M | ||
| Q3 25 | $399.7M | $344.0M | ||
| Q2 25 | $424.5M | $336.7M | ||
| Q1 25 | $454.6M | $327.2M | ||
| Q4 24 | — | $318.3M | ||
| Q3 24 | $489.3M | $309.6M | ||
| Q2 24 | $510.3M | $300.0M | ||
| Q1 24 | $577.3M | $288.9M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | $539.6M | $2.1B | ||
| Q2 25 | $557.0M | $2.0B | ||
| Q1 25 | $579.6M | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $681.5M | $2.0B | ||
| Q2 24 | $708.7M | $1.9B | ||
| Q1 24 | $777.7M | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | 0.02× | ||
| Q2 24 | 0.11× | 0.16× | ||
| Q1 24 | 0.10× | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $52.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $50.8M |
| 自由现金流率自由现金流/营收 | -118.1% | 192.3% |
| 资本支出强度资本支出/营收 | 4.5% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 4.86× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $89.9M |
8季度趋势，按日历期对齐
| Q4 25 | — | $52.6M | ||
| Q3 25 | $-22.2M | $14.1M | ||
| Q2 25 | $-20.7M | $15.6M | ||
| Q1 25 | $-30.3M | $10.9M | ||
| Q4 24 | — | $48.7M | ||
| Q3 24 | $-27.9M | $14.4M | ||
| Q2 24 | $-39.0M | $11.1M | ||
| Q1 24 | $-62.5M | $12.9M |
| Q4 25 | — | $50.8M | ||
| Q3 25 | $-23.1M | $13.6M | ||
| Q2 25 | $-22.6M | $14.9M | ||
| Q1 25 | $-35.3M | $10.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | $-30.1M | $14.2M | ||
| Q2 24 | $-41.0M | $11.0M | ||
| Q1 24 | $-63.3M | $12.8M |
| Q4 25 | — | 192.3% | ||
| Q3 25 | -118.1% | 50.5% | ||
| Q2 25 | -103.6% | 57.3% | ||
| Q1 25 | -86.6% | 41.4% | ||
| Q4 24 | — | 189.3% | ||
| Q3 24 | -136.4% | 51.5% | ||
| Q2 24 | -182.2% | 40.8% | ||
| Q1 24 | -138.9% | 50.3% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | 4.5% | 1.6% | ||
| Q2 25 | 8.7% | 2.9% | ||
| Q1 25 | 12.4% | 1.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | 10.2% | 0.6% | ||
| Q2 24 | 8.6% | 0.5% | ||
| Q1 24 | 1.7% | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 1.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NECB
暂无分部数据
